Biden's Build Back Better would do real damage to medical innovation just when we need it most
In Washington, D.C., no good deed ever seems to go unpunished. And so it is with innovators in our medical industry—companies that produce break through drugs, vaccines, and high-tech medical devices. As almost never before, these companies are under assault by Congress for the sin of being profitable. The most pernicious threat is the set of price controls on drug companies contained in the…